SSPC developing connections with Singapore

Share on facebook
Share on google
Share on twitter
Share on linkedin

SSPC hosted a selection of Singapore’s A*Star Pharmaceutical Innovation Programme, known as the Pharma Innovation Progamme Singapore (PIPS), a partnership between the Agency for Science, Technology and Research (A*Star), the National University of Singapore (NUS), the Nanyang Technological University (NTU), the Singapore Institute of Technology (SIT), and pharma companies GlaxoSmithKline (GSK), MSD International GmbH (Singapore branch) and Pfizer Asia Pacific.

The group are providing a platform to build a well-connected pharma manufacturing ecosystem that catalyses collaboration and drives the strategic evolution of pharma manufacturing capabilities in Singapore. PIPS is also engaging other firms including multinationals, large local enterprises, and small and medium-sized enterprises that are “technology enablers” which can add value to the pharmaceutical manufacturing industry.

Related News

Paper published by SSPC at University College Dublin

Paper published by SSPC at University College Dublin

Melba et al. based at University College Dublin published a paper in Chemical…

  • November 21, 2018
Eva Philbin Public Lecture Series with SSPC Co-Principal Investigator Prof. Anita Maguire

Eva Philbin Public Lecture Series with SSPC Co-Principal Investigator Prof. Anita Maguire

In conjunction with SSPC Technical Meeting being held in the Joly Lecture Theatre,…

  • November 27, 2018

Latest Post

Everything you need to know about steriods
SSPC Crystal Drop Workshop
What science goes into making medicine?

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.